In addition, hTERT is an identical target of Wnt/β-catenin signaling in cancer cells, while KLF4 directly interacts with Wnt/β-catenin signaling to suppress Wnt signaling and inhibit tumor growth [30–32]. Here, KLF4 is linked to cancer.